Implantable defibrillators in the third millennium: Increasingly relegated to a standby role?

Journal of the American College of Cardiology

Volumn 36, Issue 3, 2000, Pages 828-831

  Saksena, Sanjeev ^a,b,c  

^a Atlantic Health   (United States)

^b Electrophysiology Research Foundation   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

CLINICAL TRIAL; CONVULSIVE THERAPY; DEFIBRILLATOR; EDITORIAL; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SUDDEN DEATH; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC STIMULATION THERAPY; HUMANS; QUALITY OF LIFE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0033851653     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00802-0     Document Type: Editorial

References (28)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
2. A randomized study of the prevention of sudden death in patients with coronary artery disease
3. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study
4. Anxiety and anger in patients with ventricular tachyarrhythmias: Responses after automatic internal cardioverter-defibrillator implantation
5. Health-related quality-of-life assessment of patients with life-threatening ventricular arrhythmias
6. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy
7. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system
8. Simultaneous biphasic shocks enhance efficacy of endocardial cardioversion defibrillation in man
9. Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator
10. Clinical trials of antiarrhythmic drugs in recipients of implantable cardioverter-defibrillators
11. Reentrant ventricular rhythms in the late myocardial infarction period: Prevention of reentry by dual stimulation during basic rhythm
12. Prevention of recurrent atrial fibrillation with chronic dual site right atrial pacing
13. Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation
14. Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation
15. Benefits of new catheter mapping technology: Fact or fiction
16. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation
17. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: A meta analysis of randomized clinical trials
18. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure
19. Dynamic characterization of premature ventricular beats and ventricular tachycardias
20. Evaluation of different ventricular pacing sites in patients with severe heart failure: Results of an acute hemodynamic study
21. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation-contraction sequence in patients with depressed ventricular function
22. Triple chamber pacemaker for end-stage heart failure in a patient with a previously implanted automatic defibrillator
23. Does consistent atrial pacing algorithm prevent recurrent paroxysmal atrial fibrillation? Clinical efficacy in right atrial appendage versus interatrial septum pacing
24. Device use patterns and clinical outcome of implantable cardioverter defibrillator patients with moderate and severe impairment of left ventricular function
25. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias
26. Prevention of implantable-defibrillator shocks by treatment with sotalol
27. Radiofrequency catheter ablation of ventricular tachycardia late after myocardial infarction
28. Anatomically guided linear radiofrequency ablation during sinus rhythm for hemodynamically unstable ventricular tachycardia associated with inferior myocardial infarction